标题
Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics
作者
关键词
-
出版物
Biology-Basel
Volume 10, Issue 9, Pages 849
出版商
MDPI AG
发表日期
2021-08-31
DOI
10.3390/biology10090849
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial
- (2021) James Russell et al. ANNALS OF HEMATOLOGY
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release
- (2021) Hana Starobova et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH ‐Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA Cohort
- (2021) Vincent Esteyrie et al. ONCOLOGIST
- Chemoreduction with topotecan and vincristine: Quantifying tumor response in bilateral retinoblastoma patients
- (2021) Benjamin A. King et al. PEDIATRIC BLOOD & CANCER
- A novel flavonoid from Fissistigma cupreonitens, 5-hydroxy-7,8-dimethoxyflavanone, competitively inhibited the efflux function of human P-glycoprotein and reversed cancer multi-drug resistance
- (2021) Yu-Ning Teng et al. PHYTOMEDICINE
- Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
- (2021) Barthelemy Diouf et al. CTS-Clinical and Translational Science
- Design, synthesis and bioactivity study on 5-phenylfuran derivatives as potent reversal agents against P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell
- (2021) Ya-Sheng Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
- (2021) Monika L. Metzger et al. JOURNAL OF CLINICAL ONCOLOGY
- Autophagy Modulators in Cancer Therapy
- (2021) Kamila Buzun et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis
- (2020) Marijke Linschoten et al. Lancet Haematology
- Discovery of Novel Autophagy Inhibitors and Their Sensitization Abilities for Vincristine‐Resistant Esophageal Cancer Cell Line Eca109/VCR
- (2020) Changyu Shan et al. ChemMedChem
- Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
- (2020) Mark Roschewski et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial
- (2020) Kazuyuki Shimada et al. LANCET ONCOLOGY
- Overcoming vincristine resistance in cancer: Computational design and discovery of piperine‐inspired P‐glycoprotein inhibitors
- (2020) Safiulla Basha Syed et al. Chemical Biology & Drug Design
- Impact of ABVD chemotherapy on ovarian reserve after fertility preservation in reproductive-aged women with Hodgkin lymphoma
- (2020) Catarina Policiano et al. JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
- Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma
- (2020) Erica H. Bell et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
- (2020) Laurie H. Sehn et al. Journal of Hematology & Oncology
- A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy
- (2020) Parul Verma et al. Scientific Reports
- Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials
- (2020) Marc P. E. André et al. Cancer Medicine
- Cost-effectiveness of brentuximab vedotin in advanced stage Hodgkin’s lymphoma: a probabilistic analysis
- (2020) A. J. N. Raymakers et al. BMC CANCER
- ABVD and BEACOPP regimens’ effects on fertility in young males with Hodgkin lymphoma
- (2020) M. S. A. Amin et al. Clinical & Translational Oncology
- New Seco-DSP derivatives as potent chemosensitizers
- (2020) Qi Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mitotic Poisons in Research and Medicine
- (2020) Jan Škubník et al. MOLECULES
- Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab
- (2020) Georgios I. Papageorgiou et al. ANTI-CANCER DRUGS
- M‐EA (methotrexate, etoposide, dactinomycin) and EMA‐CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first‐line treatment of high‐risk gestational trophoblastic neoplasia
- (2020) Kam Singh et al. INTERNATIONAL JOURNAL OF CANCER
- Frontline treatment of diffuse large B‐cell lymphoma: Beyond R‐CHOP
- (2019) Patrizia Mondello et al. HEMATOLOGICAL ONCOLOGY
- Autophagy Inhibition in Childhood Nephroblastoma and the Therapeutic Significance
- (2018) Lin-Jie Li et al. CURRENT CANCER DRUG TARGETS
- Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
- (2018) Katherine Stockstill et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse Anaplasia
- (2018) Amalia Schiavetti et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
- (2018) Hagop Kantarjian et al. LANCET ONCOLOGY
- Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
- (2018) Joseph M. Connors et al. NEW ENGLAND JOURNAL OF MEDICINE
- Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
- (2018) Loredana Amoroso et al. Cancer Research and Treatment
- Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini–Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
- (2018) Elias Jabbour et al. JAMA Oncology
- Genomic chaos in peripheral blood lymphocytes of Hodgkin's lymphoma patients one year after ABVD chemotherapy/radiotherapy
- (2018) Sandra Ramos et al. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS
- Seco-4-methyl-DCK derivatives as potent chemosensitizers
- (2018) Yalan Guo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
- (2018) Tadeusz Robak et al. LANCET ONCOLOGY
- Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
- (2018) Kieron Dunleavy et al. Lancet Haematology
- A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report
- (2017) Astrid K. Gnekow et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma
- (2017) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group
- (2017) Dennis A Eichenauer et al. LANCET ONCOLOGY
- Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas
- (2017) Joseph Roswarski et al. LEUKEMIA & LYMPHOMA
- Controlling Tumor Progression with Cyclophosphamide, Vincristine, and Dacarbazine Treatment Improves Survival in Patients with Metastatic and Unresectable Malignant Pheochromocytomas/Paragangliomas
- (2017) Shiko Asai et al. Hormones & Cancer
- Combination of ofatumumab and reduced-dose CHOP for diffuse large B-cell lymphomas in patients aged 80 years or older: an open-label, multicentre, single-arm, phase 2 trial from the LYSA group
- (2017) Frédéric Peyrade et al. Lancet Haematology
- Recent advances of cocktail chemotherapy by combination drug delivery systems
- (2016) Quanyin Hu et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
- (2015) Chan Yoon Cheah et al. CURRENT OPINION IN ONCOLOGY
- Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathy
- (2015) Rita Kramer et al. FASEB JOURNAL
- A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study
- (2015) Murali Chintagumpala et al. NEURO-ONCOLOGY
- Pilot Study of Adding Vincristine, Topotecan, and Cyclophosphamide to Interval-Compressed Chemotherapy in Newly Diagnosed Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2015) Leo Mascarenhas et al. PEDIATRIC BLOOD & CANCER
- Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature
- (2014) Timo Deutschbein et al. CLINICAL ENDOCRINOLOGY
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis
- (2014) N.D. Niemeijer et al. CLINICAL ENDOCRINOLOGY
- The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
- (2014) Kali Janes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation ofIDH
- (2014) J. Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- The Leukemias: A Half-Century of Discovery
- (2014) Emil J. Freireich et al. JOURNAL OF CLINICAL ONCOLOGY
- A previously undescribed tubulin binder
- (2014) J. J. Field et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
- (2013) Kristen Ganjoo et al. LEUKEMIA & LYMPHOMA
- Pilot study of vincristine, oral irinotecan, and temozolomide (VOIT regimen) combined with bevacizumab in pediatric patients with recurrent solid tumors or brain tumors
- (2013) Lars Wagner et al. PEDIATRIC BLOOD & CANCER
- Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
- (2013) Rajkumar Venkatramani et al. PEDIATRIC BLOOD & CANCER
- A Phase I Study of Vincristine, Irinotecan, Temozolomide and Bevacizumab (Vitb) in Pediatric Patients with Relapsed Solid Tumors
- (2013) Rajkumar Venkatramani et al. PLoS One
- Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity
- (2012) Ibrahim Qaddoumi et al. CANCER
- EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
- (2012) Constantine Alifrangis et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Advanced Medullary Thyroid Carcinoma with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine: a Single-Center Experience
- (2011) T. Deutschbein et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search